Exact Mass: 468.2172726
Exact Mass Matches: 468.2172726
Found 241 metabolites which its exact mass value is equals to given mass value 468.2172726
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Henatinib
Ruboxistaurin
1,2-Dihydro-8-hydroxyisopentanyl-2-methoxy-4-O-methylalpinumisoflavone
1,2-Dihydro-8-hydroxyisopentanyl-3-methoxy-4-O-methylalpinumisoflavone
lomerizine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
3,5-dihydroxy-6-methyl-octanoic acid 5-O-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinofuranoside|5-O-alpha-L-rhamnopyranosyl-(1 -> 2)-alpha-L-arabinofuranosyl 3,5-dihydroxy-6-methyl-octanoic acid
6-O-(beta-D-glucopyranosyl)-1-O-octanoyl-beta-D-glucopyranose|6-O-beta-D-glucopyranosyl-1-O-octanoyl-beta-D-glucopyranose|nonioside C
17-acetoxy-1-acetyl-10,11-dimethoxy-4-methyl-3,4-seco-cura-18,20-dien-3-one|Strychnosilin|Strychnosiline
Me glycoside,hexa-Me,6-Me ester-2-O-beta-D-Glucopyranuranuronosyl-D-mannose
(1S,4S,5R,7R,9S,10S)-9-benzoyloxy-1-(3-furoyloxy)-4-hydroxy-dihydro-beta-agarofuran
2-O-(beta-D-glucopyranosyl)-1-O-octanoyl-beta-D-glucopyranose
17-defurano-17-(2,5-dihydro-2-oxofuran-3-yl)-28-deoxonimbolide|methyl (2aR,5aR,6S,6aR,8R,9aR,10aS,10bR,10cS)-8-(2,5-dihydro-2-oxo-3-furanyl)-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-5-oxo-2H,5H-cyclopenta[d]naphtho[2,3-b:1,8-bc]difuran-6-acetate
5,3?-dihydroxy-7,4?-dimethoxy-6,8-dimethylallyl-2,3-dihydroflavonol|prenyl-isotirumalin
3-(2-hydroxypropyl)-9-(3-hydroxy-6,8-dimethyldeca-2,4,6-trienoyl)-(6aR)-6a-methyl-9,9a-dihydro-6aH-furo[2,3-h]isochromene-6,8-dione|sassafrin A
Ala His Asn Gln
Ala His Gln Asn
Ala Asn His Gln
Ala Asn Gln His
Ala Gln His Asn
Ala Gln Asn His
Cys His Ile Pro
Cys His Leu Pro
Cys His Pro Ile
Cys His Pro Leu
Cys Ile His Pro
Cys Ile Pro His
Cys Leu His Pro
Cys Leu Pro His
Cys Pro His Ile
Cys Pro His Leu
Cys Pro Ile His
Cys Pro Leu His
Phe Thr Thr Thr
C21H32N4O8 (468.22200319999996)
Gly His Gln Gln
Gly Gln His Gln
Gly Gln Gln His
His Ala Asn Gln
His Ala Gln Asn
His Cys Ile Pro
His Cys Leu Pro
His Cys Pro Ile
His Cys Pro Leu
His Gly Gln Gln
His Ile Cys Pro
His Ile Pro Cys
His Leu Cys Pro
His Leu Pro Cys
His Asn Ala Gln
His Asn Gln Ala
His Pro Cys Ile
His Pro Cys Leu
His Pro Ile Cys
His Pro Leu Cys
His Gln Ala Asn
His Gln Gly Gln
His Gln Asn Ala
His Gln Gln Gly
Ile Cys His Pro
Ile Cys Pro His
Ile His Cys Pro
Ile His Pro Cys
Ile Pro Cys His
Ile Pro His Cys
Ile Ser Ser Tyr
C21H32N4O8 (468.22200319999996)
Ile Ser Tyr Ser
C21H32N4O8 (468.22200319999996)
Ile Tyr Ser Ser
C21H32N4O8 (468.22200319999996)
Leu Cys His Pro
Leu Cys Pro His
Leu His Cys Pro
Leu His Pro Cys
Leu Pro Cys His
Leu Pro His Cys
Leu Ser Ser Tyr
C21H32N4O8 (468.22200319999996)
Leu Ser Tyr Ser
C21H32N4O8 (468.22200319999996)
Leu Tyr Ser Ser
C21H32N4O8 (468.22200319999996)
Asn Ala His Gln
Asn Ala Gln His
Asn His Ala Gln
Asn His Gln Ala
Asn Gln Ala His
Asn Gln His Ala
Pro Cys His Ile
Pro Cys His Leu
Pro Cys Ile His
Pro Cys Leu His
Pro His Cys Ile
Pro His Cys Leu
Pro His Ile Cys
Pro His Leu Cys
Pro Ile Cys His
Pro Ile His Cys
Pro Leu Cys His
Pro Leu His Cys
Gln Ala His Asn
Gln Ala Asn His
Gln Gly His Gln
Gln Gly Gln His
Gln His Ala Asn
Gln His Gly Gln
Gln His Asn Ala
Gln His Gln Gly
Gln Asn Ala His
Gln Asn His Ala
Gln Gln Gly His
Gln Gln His Gly
Ser Ile Ser Tyr
C21H32N4O8 (468.22200319999996)
Ser Ile Tyr Ser
C21H32N4O8 (468.22200319999996)
Ser Leu Ser Tyr
C21H32N4O8 (468.22200319999996)
Ser Leu Tyr Ser
C21H32N4O8 (468.22200319999996)
Ser Ser Ile Tyr
C21H32N4O8 (468.22200319999996)
Ser Ser Leu Tyr
C21H32N4O8 (468.22200319999996)
Ser Ser Tyr Ile
C21H32N4O8 (468.22200319999996)
Ser Ser Tyr Leu
C21H32N4O8 (468.22200319999996)
Ser Thr Val Tyr
C21H32N4O8 (468.22200319999996)
Ser Thr Tyr Val
C21H32N4O8 (468.22200319999996)
Ser Val Thr Tyr
C21H32N4O8 (468.22200319999996)
Ser Val Tyr Thr
C21H32N4O8 (468.22200319999996)
Ser Tyr Ile Ser
C21H32N4O8 (468.22200319999996)
Ser Tyr Leu Ser
C21H32N4O8 (468.22200319999996)
Ser Tyr Ser Ile
C21H32N4O8 (468.22200319999996)
Ser Tyr Ser Leu
C21H32N4O8 (468.22200319999996)
Ser Tyr Thr Val
C21H32N4O8 (468.22200319999996)
Ser Tyr Val Thr
C21H32N4O8 (468.22200319999996)
Thr Phe Thr Thr
C21H32N4O8 (468.22200319999996)
Thr Ser Val Tyr
C21H32N4O8 (468.22200319999996)
Thr Ser Tyr Val
C21H32N4O8 (468.22200319999996)
Thr Thr Phe Thr
C21H32N4O8 (468.22200319999996)
Thr Thr Thr Phe
C21H32N4O8 (468.22200319999996)
Thr Val Ser Tyr
C21H32N4O8 (468.22200319999996)
Thr Val Tyr Ser
C21H32N4O8 (468.22200319999996)
Thr Tyr Ser Val
C21H32N4O8 (468.22200319999996)
Thr Tyr Val Ser
C21H32N4O8 (468.22200319999996)
Val Ser Thr Tyr
C21H32N4O8 (468.22200319999996)
Val Ser Tyr Thr
C21H32N4O8 (468.22200319999996)
Val Thr Ser Tyr
C21H32N4O8 (468.22200319999996)
Val Thr Tyr Ser
C21H32N4O8 (468.22200319999996)
Val Tyr Ser Thr
C21H32N4O8 (468.22200319999996)
Val Tyr Thr Ser
C21H32N4O8 (468.22200319999996)
Tyr Ile Ser Ser
C21H32N4O8 (468.22200319999996)
Tyr Leu Ser Ser
C21H32N4O8 (468.22200319999996)
Tyr Ser Ile Ser
C21H32N4O8 (468.22200319999996)
Tyr Ser Leu Ser
C21H32N4O8 (468.22200319999996)
Tyr Ser Ser Ile
C21H32N4O8 (468.22200319999996)
Tyr Ser Ser Leu
C21H32N4O8 (468.22200319999996)
Tyr Ser Thr Val
C21H32N4O8 (468.22200319999996)
Tyr Ser Val Thr
C21H32N4O8 (468.22200319999996)
Tyr Thr Ser Val
C21H32N4O8 (468.22200319999996)
Tyr Thr Val Ser
C21H32N4O8 (468.22200319999996)
Tyr Val Ser Thr
C21H32N4O8 (468.22200319999996)
Tyr Val Thr Ser
C21H32N4O8 (468.22200319999996)
Ruboxistaurin
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors
(R)-(+)-2,2-Bis[di(3,5-di-t-butylphenyl)phosphino]-6,6-dimethoxy-1,1-biphenyl,min.
beta-D-Fructofuranosyl 6-O-octanoyl-alpha-D-glucopyranoside
(1S,12R,23R)-16-acetyl-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetrazahexacyclo[12.10.0.02,11.04,9.015,23.017,22]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione
2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-hydroxy-5-phosphonopentanoic acid
2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-5-(2-hydroxy-3-morpholin-4-ylpropyl)-3-methyl-1,6,7,8-tetrahydropyrrolo[3,2-c]azepin-4-one
1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-3-(4-fluorophenyl)-1-[2-(1-pyrrolidinyl)ethyl]urea
2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C22H30F2N4O5 (468.21841539999997)
Leu-Ser-Ser-Tyr
C21H32N4O8 (468.22200319999996)
A tetrapeptide composed of L-leucine, two L-serine units and L-tyrosine joined in sequence by peptide linkages.
3-[(4R,5R)-4-carbamoyl-2-[4-(3-hydroxypropoxy)phenyl]-5-phenyl-5H-oxazol-4-yl]propanoic acid tert-butyl ester
2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C22H30F2N4O5 (468.21841539999997)
2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C22H30F2N4O5 (468.21841539999997)
2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C22H30F2N4O5 (468.21841539999997)
[(1S)-1-(hydroxymethyl)-7-methoxy-1-(phenylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(3-pyridinyl)methanone
2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C22H30F2N4O5 (468.21841539999997)
2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C22H30F2N4O5 (468.21841539999997)
2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C22H30F2N4O5 (468.21841539999997)
2-[(2S,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[3-(4-morpholinyl)propyl]acetamide
C22H30F2N4O5 (468.21841539999997)
[(8R,9S,10R)-9-[4-(3-methoxyprop-1-ynyl)phenyl]-6-(2-methylphenyl)sulfonyl-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(1R)-1-(hydroxymethyl)-7-methoxy-1-(phenylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-(3-pyridinyl)methanone
BAY-3827
C27H25FN6O (468.20737719999994)
BAY-3827 is a potent and selective AMPK inhibitor with IC50 values of 1.4 nM at low (10 μM ATP concentration) and 15 nM at high (2 mM ATP concentration). BAY-3827 shows over 500-fold selectivity for most of the 331 kinases. BAY-3827 prevents phosphorylation of acetyl-CoA carboxylase 1 and shows strongest anti-proliferative activity in androgen-dependent prostate cancer cell lines[1].